![]() |
Mesoblast Limited (Asx:MSB) Gains Us Fda Clearance For Phase 2 Trial... (Topix)
Main Category: Neurology / Neuroscience Also Included In: Clinical Trials / Drug Trials ; Regulatory Affairs / Drug Approvals Article Date: 17 Aug 2009 - 5:00 PDT Australian regenerative medicine company, Mesoblast Limited , announced that it has received clearance from the United States Food and Drug Administration for a Phase 2 clinical trial of ...
More... (From Topix Neurology) |
All times are GMT -5. The time now is 02:51 AM. |
Powered by vBulletin Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise (Lite) -
vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.